Introduction {#Sec1}
============

Metabolic syndrome was defined by, WHO, NCEP ATP III and IDF etc. National cholesterol education program's adult treatment panel III (NCEPATP III) defines metabolic syndrome as having three or more of the five risk factors: raised fasting plasma glucose, high blood pressure, abdominal obesity, low HDL, and/or raised plasma triglyceride \[[@CR1]\]. The world health organization (WHO) defines metabolic syndrome as insulin resistance \[impaired glucose tolerance (IGT) or diabetes\] to be present for the diagnosis to be made. In addition to insulin resistance, at least two other components must also be present: obesity, hypertension, dyslipidemia and/or micro albuminuria \[[@CR2]\].

Because of the study patients are type 2 DM, we select IDF criteria to define MetS. This is particularly evident for the risk of type 2 DM, which is apparent at much lower levels of obesity in Asians compared to Europeans. The IDF, having recognized the difficulties in identifying unified criteria for MetS that were applicable across all ethnicities, has proposed a new set of criteria with ethnic/racial specific cut-offs and IDF states that because of the limited data in Sub-Saharan Africa including Ethiopia, they should use European criteria \[[@CR3]\].

According to the new international diabetes federation (IDF) definition, metabolic syndrome is defined as central obesity (defined by waist circumference) plus any two of the four risk factors: raised triglyceride, low high density lipoprotein (HDL) cholesterol, raised blood pressure and/or raised fasting plasma glucose level. Metabolic syndrome is a complex disorder which leads type 2 diabetes patients and cardiovascular disease (CVD) to be a twin global epidemic problem \[[@CR4]\].

About 70--80% of diabetes mellitus (DM) \[[@CR5]\] and 20--25% of adult population in the world is estimated to have metabolic syndrome and they are two times as likely to die from and three-fold as likely to have a heart attack or stroke as compared to without the syndrome. Besides, metabolic syndrome has five times increased risk of acquiring type 2 diabetes mellitus \[[@CR6]\]. Consumption of calorie-dense foods, sedentary lifestyle, and tobacco consumption are considered as potential risk factors for MetS \[[@CR7]\]. In Ethiopia, the prevalence of metabolic syndrome among type 2 diabetes mellitus according to NCEP on (ATP) III was 45.9% \[[@CR8]\].

There is limited data on metabolic syndrome in Ethiopia and in the horn of Africa at large. Therefore, this study is helpful to the development of life style modification, control and management of the metabolic syndrome. Finally, this will bring non-communicable disease in general and metabolic syndrome in particular into the clinical area, and research agenda.

Main text {#Sec2}
=========

Methods and patients {#Sec3}
--------------------

### Study setting and period {#Sec4}

A hospital based cross section study design was conducted in Ayder Comprehensive Specialized Hospital (ACSH) from February to June 2018. ACSH is found in Mekelle the capital city of Tigray region northern of Ethiopia. Mekelle is located around 780 km north of the Ethiopian capital city Addis Ababa. The study participants were previously diagnosed/known type 2 DM patients. DM clinic is served for about 500 type 2 DM patients per month that is estimated from the average of the last 6 months report.

Study design: A hospital based cross section study design.

Source patients: All type 2 diabetes patients attending DM clinic at ACSH.

Study patients: All volunteer type 2 DM patients attending DM clinic and available at ACSH during the data collection period.

Study subjects: All sampled subjects (419) participated in this study.

#### Inclusion criteria {#Sec5}

All type 2 diabetes mellitus patients.

#### Exclusion criteria {#Sec6}

Critically ill patient.Pregnant mother (difficult to measure BMI and waist circumference).

### Sample size determination {#Sec7}
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Considering 10% non-response rate, because of some respondents may withdraw in between the interview, the total estimated study subjects were 419 and selected by systematic random sampling technique with kth interval of 2 and every second (2) was participated by random selection from 1 to 2(kth).

### Data collection procedure {#Sec8}

Data collection was carried out from February to March 2018. To collect data a standardized, interviewer administered questionnaire and document review checklist of physical measurements, residence (urban or rural) for the last 6 month, co-morbid disease like hypertension, CHF, stroke were used and contains three parts. Thus are socio-demographic and medical history, the life style and related information.

### Measurements and tools {#Sec9}

Anthropometric measurements: Anthropometric measurements of weight and height was measured using Seca weighing scale and stadiometer respectively and participants were wearing light clothing (single and thin) and without shoes to the nearest Kg and CM respectively. A simple flexible steel metric tape calibrated in meters was used for measuring waist circumference. Waist circumference was measured midway between the iliac crest and the lower rib margin in the horizontal plane while the participant is standing to the nearest 0.5 cm.

#### Blood pressure {#Sec10}

Two blood pressure measurements taken after 5 min apart were determined for each participant using standard adult digital blood pressure apparatus with the correct size arm cuff. Participants was measured after 5 min of rest in sitting position, arm should be rest on table at heart level, back supported, on the same arm and legs rest on ground (no crossed). And the average readings of the two measurements was recorded in questionnaire \[[@CR9]\].

### Data quality assurance {#Sec11}

Questionnaire was prepared in English and translated into local language Tigrigna by expert in language. Pretest was done on 5% of the subjects in Mekelle hospital 2 weeks before the actual data collection. Because Mekelle hospital is near to ACSH and have similar socio-demographic characteristics with patients in ACSH. Two BSC nurses and one supervisor were recruited for data collection and training was given. The collected data was checked by supervisor and principal investigator daily.

### Data processing and analysis {#Sec12}

After the data collection, the data was entered into Epi-info version 7 and exported to SPSS version 23 statistical program. Descriptive characteristics were presented in text, frequency percentage tables, and graphs. Binary logistic regression model was used to see the association between the outcome variable with each independent variables. Then those variables with P-value \< 0.25 at bivariate analysis was included in the multivariable analysis. Finally P-value \< 0.05 is describe as a statistically associated with 95% confidence level. Model fitness was checked by using Hosmer and Lemeshow goodness fit model.

### Operational definition {#Sec13}

#### Metabolic syndrome {#Sec14}

As per the definition of international diabetes federation it is defined as having central obesity (defined by waist circumference ≥ 94 cm for male and ≥ 80 cm for female) plus any two of the following four factors: raised triglycerides, reduced HDL cholesterol, raised blood pressure, and/or raised fasting plasma glucose.

#### Central obesity {#Sec15}

defined by waist circumference ≥ 94 cm for male and ≥ 80 cm for female putting to the nearest centimeter.

#### Raised triglycerides {#Sec16}

≥ 150 mg/dL (1.7 mmol/L) or specific treatment for this lipid abnormality.

#### Reduced HDL cholesterol {#Sec17}

\< 40 mg/dL (1.03 mmol/L) in male \< 50 mg/dL (1.29 mmol/L) in female or specific treatment for this lipid abnormality.

#### Raised blood pressure {#Sec18}

Is a systolic BP ≥ 130 mm Hg or diastolic BP ≥ 85 mm Hg, or any patient on treatment of previously diagnosed hypertension.

#### Reduce salt intake {#Sec19}

About 1 tea spoon of table salt per meal.

Result {#Sec20}
------

### Socio-demographic characteristics {#Sec21}

A total of 419 type 2 DM patients were enrolled in this study. Binary logistic regression was used. Of these respondents 211 (50.4%) were females. The mean age of the respondents was 56.39 SD ± 10.18 with minimum of 35 and maximum of 90 years old. Of the total respondents 79.7% were married, 83.1% were orthodox Christian followers (Table [1](#Tab1){ref-type="table"}).Table 1Frequency distribution of socio-demographic characteristics of respondents among type 2 diabetes mellitus patients in ACSH, Tigray, Ethiopia (n = 419)VariableCategoryNo.PercentSexFemale21150.4Male20849.6Ethnicity of participantsTigray39594.3Amara245.7Marital statusSingle194.5Married33479.7Divorced245.7Widowed4210ReligionOrthodox34883.1Muslim6515.5Protestant61.4Occupation of participantFarmer5011.9Merchant11026.3G. Employed11527.4Daily laborer256House wife7818.6P. Employed419.8Educational statusUnable to read and write13131.3Primary school11828.2High school6916.5College and above10124.1Place of residenceUrban36186.2Rural5813.8N.B: G. employed: government employed, P. employed: private employed

### Metabolic syndrome and its component {#Sec22}

According to IDF criteria 51.1% of the respondents had metabolic syndrome, with higher prevalence in females when compared to males (57.5% and 42.5% respectively). Central obesity (59.7%) was highly prevalent component of metabolic syndrome followed by elevated triglyceride (45.1%) and then hypertension and low HDL-c 41.3% and 34.4% respectively. Females were also having higher proportion of central obesity and reduced HDL than males (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1Frequency of component of MetS in relation to sex of respondents among type 2 patients with DM in ACSH, Tigray, Ethiopia, 2019 (n = 419)

### Factors associated to metabolic syndrome {#Sec23}

In the multivariable analysis, age \[AOR (95% CI) 1.04 (1.01, 1.07)\], sex \[AOR (95% CI) 1.94 (1.06, 3.54)\], eating fruits once, twice, and four and above times in a typical week \[AOR (95% CI) 0.41 (0.21, 0.78), 0.35 (0.16, 0.76), and 0.24 (0.07, 0.75)\], regular physical exercise \[AOR 1.83 (1.05, 3.36)\], family history of DM \[AOR (95% CI) 0.54 (0.29, 0.99)\], chronic disease co-morbid \[AOR 0.42 (0.25, 0.70)\] Overweight \[AOR (95% CI) 2.66 (1.50, 4.69)\] and obesity \[AOR 3.50 (1.23, 9.91)\] shows statistical association with metabolic syndrome (Table [2](#Tab2){ref-type="table"}).Table 2Multivariable analysis of the independent variables with metabolic syndrome among patients with type 2 diabetes mellitus in ACSH, Mekelle, Tigray, Ethiopia (n = 419)VariablesMetabolic syndromeCrude ORAdjusted ORNoYesP-value95% CIP-value95% CISex Male1179111 Female881230.0031.79 (1.22, 2.64)*0.0311.94(1.06, 3.54)*\*Age0.001.05 (1.03, 1.08)*0.0051.04 (1.01, 1.07)*\*Ethnicity of participant Tigray (Ref)18720811 Amara1860.0120.3 (0.11, 0.77)0.13570.40 (0.11, 1.42)Marital status0.0680.549 Single14511 Married1641700.0452.9 (1.02, 8.24)0.2872.01 (0.55, 7.32) Divorced12120.122.8 (0.76, 10.24)0.5091.73 (0.34, 8.79) Widowed15170.0085.04 (1.52, 16.7)0.1572.97 (0.65, 13.50)Occupation0.0020.322 Farmer371311 Merchant52580.023.17 (1.52, 6.62)0.0623.36 (0.94, 12.01) Government employee57580.042.89 (1.39, 6.01)0.0393.88 (1.07, 14.06) Daily laborer14110.1192.24 (0.82, 6.15)0.2942.25 (0.49, 10.24) House wife33450.0013.88 (1.78, 8.43)0.0733.3 (0.89, 12.22) Private employee12290.006.87 (2.73, 17.31)0.0274.78 (1.19, 19.11)Residence of participant Urban16319811 Rural42160.000.31 (0.17, 0.57)0.8171.14 (0.37, 3.45)Physical exercise Yes603411 No1451800.0012.19 (1.36, 3.52)*0.0481.83 (1.05, 3.36)*\*Eat fruits in a typical week0.221*0.027* None per week547811 One times a week83770.0620.64 (0.4, 1.02)*0.0070.41 (0.21, 0.78)*\* Twice a week42360.070.59 (0.34, 1.04)*0.0080.35 (0.16, 0.76)*\* Three times a week1170.1110.44 (0.16, 1.20)0.0880.31(0.08, 1.18) Four and above a week15160.4490.74 (0.36, 1.62)*0.0140.24 (0.07, 0.75)*\*Eat vegetablesin a typical week0.0280.068 None per week172211 One times a week37210.0510.43 (0.19, 1.05)0.1220.42 (0.14, 1.25) Twice a week69580.2420.65 (0.31, 1.33)0.3450.62 (0.23, 1.66) Three times a week28430.6721.18 (0.53, 2.62)0.6501.27 (0.44, 3.65) Four and above a week54700.9961.02 (0.48, 2.07)0.7181.21 (0.43, 3.40)Any alcoholic drinks Yes312311 No1741910.1831.48 (0.83, 2.63)0.6111.23 (0.54, 2.78)Ever smoke any tobacco product ever Yes2611 No2032080.1910.34 (0.68, 1.72)0.0920.17 (0.02, 1.33)Low salt intake Yes14817411 No57400.0280.59 (0.37, 0.94)0.3440.074 (0.41, 1.36)Body mass index0.0000.001 Normal weight14710811 Underweight1510.0210.91 (0.01, 0.69)0.0890.14 (0.01, 1.34) Overweight37760.0002.79 (1.76, 4.45)*0.0012.66 (1.50, 4.69)*\* Obese6290.0006.58 (2.64, 16.4)*0.0183.50 (1.23, 9.91)*\*Duration of DM0.0000.038 \< 5 years duration1348411 6--10 years duration46630.0012.18 (1.37, 3.48)0.3341.35 (0.73, 2.50) \> 10 years duration25670.0004.27 (2.5, 7.29)*0.0102.49 (1.23, 5.01)*\*Treatment0.0120.073 Metformin705711 Glibenclamide1340.1040.38 (0.12, 1.22)0.1560.35 (0.08, 1.47) Metformin plus glibenclamide67700.3131.28 (0.79, 2.08)0.6040.84 (0.45, 1.58) Insulin plus oral hypoglycemic agents55830.0131.85 (1.14, 3.02)0.1481.62 (0.84, 3.12)Family hx of DM Yes337411 No1721400.0000.36 (0.228, 0.58)*0.0470.54 (0.29, 0.99)*\*Chronic disease Yes7012311 No135910.0000.38 (0.26, 0.57)*0.0010.42 (0.25, 0.70)*\*N.B; \* states significant association, and 1; reference category

Discussion {#Sec24}
----------

This study was aimed to assess magnitude of metabolic syndrome and its associated factors among type 2 DM patients who have follow up in ACSH.

The magnitude of metabolic syndrome among type 2 DM patients in this study was 51.1%; which lies within a range of 12--86% from a review study done in sub Saharan Africa \[[@CR10]\]. But, this study is higher than from a study conducted in Ethiopia (45.9%), in 10 European countries (24%) and UK (32%) \[[@CR8], [@CR11]\]. This difference is due to difference in study setting, sample size, and the criteria used to define metabolic syndrome. The magnitude of MetS in this study is lower than from studies done in Gahanna (68.6%), Nigeria (68.7%) and Iran (64.9%) \[[@CR12]--[@CR14]\].This variation could be due to difference in socio-cultural, study setting, study design and life style.

This study reveals that, age was significantly associated with metabolic syndrome, and this is in line with a study conducted in Iran \[[@CR12]\]. This association might be due to older age participants were physically inactive and adoption of unhealthy life styles. Sex was another variable that shows statistical association with metabolic syndrome. This is consistent with studies in Hawassa Ethiopia, Addis Ababa Ethiopia, Nigeria, and Iran \[[@CR8], [@CR12], [@CR13], [@CR15]\].

Respondents who eat fruit twice, four and above times in a typical week were 65% and 76% protected from metabolic syndrome respectively as compared to those who never eat fruit in a typical week. This is supported by EPHA (Ethiopia) and in line with study conducted in brazil \[[@CR16], [@CR17]\].

Respondents who did not do regular physical exercise were 1.83 odds to have MetS as compared to those who did regular physical exercise. This is supported by EPHA report (Ethiopia) and in line with studies done in US, Canada, and Sub-Saharan Africa \[[@CR16], [@CR18]--[@CR20]\].

In addition, the odds of MetS were 2.66 and 3.5 times higher among overweight and obesity compared to those normal weigh respondents respectively among type 2 DM patients. This is in line with studies done in Ethiopia, Gahanna, Iran and Nigeria \[[@CR8], [@CR12], [@CR13], [@CR21]\]. But lower in AOR from a study in Ethiopia. This may be due to sample size and difference in reference category.

Conclusion and recommendation {#Sec25}
-----------------------------

### Conclusion {#Sec26}

The magnitude of metabolic syndrome among type 2 diabetes mellitus is 51.5%. The associated factors for metabolic syndrome are physical inactivity, advanced age, inadequate intake of fruits, family history, overweight and obesity.

### Recommendations {#Sec27}

#### To Ayder Comprehensive Specialized Hospital {#Sec28}

Regular screening of type 2 DM patients in ACSH for components of MetS is vital in order to avert/limit the risks before developing cardiovascular related morbidity and mortality.

#### To type 2 DM in ACSH {#Sec29}

Should do regular physical exercise as recommended.Should reduce and manage their weight if they are told to do so by health care professionals.

#### To further study {#Sec30}

Further cohort or interventional studies should be done to address other predictors of MetS.

Limitation of the study {#Sec31}
=======================

The cross sectional nature of the study; temporal relationship between exposure and disease cannot be clearly determined or not powerful.The study was conducted only in a single public hospital.
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